Qiong Lu
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 5
-
- MicroRNA in disease regulation 19
- Cancer-related molecular mechanisms research 12
- Co-authors
- Chenyan Zhao (6 shared papers)Jianhui Nie (8 shared papers)Weijin Huang (8 shared papers)Youchun Wang (7 shared papers)Qianqian Li (5 shared papers)Jiajing Wu (8 shared papers)Qiyu Sun (4 shared papers)Li Zhang (4 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (5 papers)Biochemical and Biophysical Research Communications (3 papers)Infection and Drug Resistance (3 papers)Cell Proliferation (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Qiong Lu
81 papers receiving 4.5k citations
Qiong Lu's Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 1.6k
- Cancer Research 980
- Molecular Biology 2.0k
- Animal Science and Zoology 277
- Oncology 588
Countries citing papers authored by Qiong Lu
This map shows the geographic impact of Qiong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiong Lu more than expected).
Fields of papers citing papers by Qiong Lu
This network shows the impact of papers produced by Qiong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiong Lu. The network helps show where Qiong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity Hit paper breakdown → | 2020 | 957 |
| 2 | Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 Hit paper breakdown → | 2020 | 449 |
| 3 | 2015 | 418 | |
| 4 | 2012 | 413 | |
| 5 | 2020 | 241 | |
| 6 | 2016 | 235 | |
| 7 | 2017 | 167 | |
| 8 | 2013 | 116 | |
| 9 | 2017 | 91 | |
| 10 | 2010 | 84 | |
| 11 | 2008 | 68 | |
| 12 | 2013 | 63 | |
| 13 | 2014 | 59 | |
| 14 | 2021 | 58 | |
| 15 | Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer. | 2020 | 56 |
| 16 | 2015 | 54 | |
| 17 | 2012 | 50 | |
| 18 | 2014 | 50 | |
| 19 | 2013 | 47 | |
| 20 | 2013 | 43 |
About Qiong Lu
Qiong Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Infectious Diseases, having authored 87 papers that have together received 4.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), CAR-T cell therapy research (6 papers), RNA modifications and cancer (5 papers), Immunotherapy and Immune Responses (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Cancer Research (980 citations), Molecular Biology (2.0k citations), Animal Science and Zoology (277 citations) and Oncology (588 citations). Qiong Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Chenyan Zhao, Jianhui Nie, Weijin Huang, Youchun Wang, Qianqian Li, Jiajing Wu, Qiyu Sun, Li Zhang, Meng Wang and Lingling Nie. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Biochemical and Biophysical Research Communications, Infection and Drug Resistance, Cell Proliferation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.